Related Experiment Video
Updated: Nov 3, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Abyssomicins-A 20-Year Retrospective View.
1Department of Microbiology/Biotechnology, Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), University of Tuebingen, Auf der Morgenstelle 28, D-72076 Tübingen, Germany.
New abyssomicins from marine bacteria show potent antibiotic activity against resistant Gram-positive bacteria. These compounds selectively inhibit a key enzyme in folic acid synthesis.
Area of Science:
- Marine microbiology
- Natural product chemistry
- Antibiotic discovery
Background:
- Abyssomicins are a novel class of polycyclic macrolactones.
- The marine actinomycete Verrucosispora maris AB-18-032 produces abyssomicins B, C, atrop-C, and D.
- These were isolated from Japanese Sea sediment.
Purpose of the Study:
- To characterize the antibiotic properties of abyssomicins.
- To identify the mechanism of action for active abyssomicins.
Main Methods:
- Isolation and characterization of abyssomicins from Verrucosispora maris.
- Antibacterial activity screening against Gram-positive bacteria.
- Enzyme inhibition assays targeting 4-amino-4-deoxychorismate synthase.
Main Results:
- Abyssomicin C and atrop-abyssomicin C exhibit significant activity against multi-resistant and vancomycin-resistant Gram-positive bacteria.
- The mechanism involves selective inhibition of 4-amino-4-deoxychorismate synthase.
- This enzyme is crucial for para-aminobenzoic acid synthesis in the folic acid pathway.
Conclusions:
- Abyssomicin C and atrop-abyssomicin C are promising leads for novel antibiotic development.
- Targeting the folic acid pathway via 4-amino-4-deoxychorismate synthase is a viable strategy against resistant bacteria.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Antibiotic Selection

